Delivery Order SPE2DB24D2205-SPE2DB25FEETY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,414.44 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $27,178.87 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $7,207.26 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 2, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete openly in...
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.30 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a completion date of July 31, 2025. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a $1,801.47 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 30. This firm fixed price contract, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was not set aside for small business or other designated categories and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,124.22 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units). This competitively awarded, firm fixed-price delivery order was executed on July 29, 2025, with a completion deadline of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEETYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,163.11 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing contract vehicle. The award was made through open competition with no set-aside designation, and performance will be executed at the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems globally. The company's portfolio encompasses generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains, enabling it to fulfill diverse healthcare requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.2k | 7/11/25 |